Accepted answer
95.2 and 98.4 are 3.2 percentage points apart, which sounds small until you restate it as impurity. Medutest is leaving 4.8 per cent of the detected area unassigned and Janoshik 1.6 per cent — a factor of 3 between them. The impurity fraction is the quantity that moves when a method changes, and it is the one worth arguing about; the headline is just its complement. Comparable means same column chemistry, same gradient slope, same detection wavelength, same integration convention. Until you have those four from both laboratories, 95.2 and 98.4 are two measurements of slightly different quantities that happen to share a unit.
Understanding purity requires separating the chemistry from the method from the reporting convention, and the three are not independent.
Temperature affects the dynamics of molecular conformation, and if a peptide has proline residues that interconvert on the chromatographic timescale, the peak will split or shoulder at low temperature and collapse at high temperature.
Concretely, integration of the shoulder — whether you use perpendicular drop or tangent skim — determines what area gets assigned to the main peak versus the impurity table.
The ICH Q3A impurity thresholds and the relevant pharmacopoeial chapters all specify method validation requirements that almost no research-grade certificate claims to meet.
If you are ranking vendors, specify a method and have all samples tested at the same place.
6Adding for future readers: the certificate should carry the lot number, not just a batch code. – eoin_mcgarry 18 days ago 5The distinction between purity and content cannot be repeated often enough here. – deamidation_watch 9 months ago add a comment